SPY416.07+3.90 0.95%
DIA341.30+3.18 0.94%
IXIC13,950.22+163.95 1.19%

Pliant Therapeutics Q4 EPS $(0.54), Sales $4.46M

Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.54) per share. The company reported $4.46 million in sales this quarter.

· 03/16/2021 16:11
Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.54) per share. The company reported $4.46 million in sales this quarter.